2,4-二羟基-6-十五烷基苯甲酸 | 52189-70-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2,4-二羟基-6-十五烷基苯甲酸
• 英文名称: corticiolic acid
• 英文别名: 6-n-Pentadecyl-2,4-dihydroxybenzoic acid；2,4-dihydroxy-6-pentadecylbenzoic acid
• CAS: 52189-70-5
• 化学式: C₂₂H₃₆O₄
• 分子量: 364.525
• InChiKey: HSTMNVBDDNVTBN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.1
• 重原子数：
  26
• 可旋转键数：
  15
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  77.8
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2,4-二羟基-6-十五烷基苯甲酸 在 4-二甲氨基吡啶 、 palladium on activated carbon 、 氢气 、 potassium hydrogencarbonate 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 silver(l) oxide 作用下， 以 氯仿 、 乙酸乙酯 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 18.0h， 生成 benzyl 4'-(4-O-(methyl 2'',3'',4''-tri-O-acetyl-β-D-glucopyranosyluronate)-2-hydroxy-6-pentadecanylbenzoyloxy)-2'-benzyloxy-6'-methylbenzoate
  参考文献：
  名称：

  新型四氢咪唑并[1,2-a]吡啶-5-羧酸衍生物作为有效乙酰肝素酶-1 抑制剂的先导鉴定

  摘要：

  乙酰肝素酶 1 (HPSE1) 是一种内切-β- d - 葡萄糖醛酸酶，可将硫酸乙酰肝素蛋白多糖切割成短链硫酸乙酰肝素 (HS)。HPSE1 的抑制对肾病综合征等蛋白尿疾病具有治疗潜力，因为 HPSE1 表达增加与肾小球基底膜中 HS 的丢失有关，从而导致蛋白尿的发展。本研究检查了先导化合物的生成，重点关注具有糖基的化学结构，例如糖苷和糖类似物，同时考虑了它们的物理特性。化合物10是一种外切-β- d -葡萄糖醛酸酶 (GUSβ) 抑制剂，被发现对内切具有微弱的抑制活性-β- d -葡萄糖醛酸酶 HPSE1。使用10和 HPSE1的 X 射线共晶结构进行的构效关系研究产生了12a ，与10相比，其 HPSE1 抑制活性增加了 14 倍以上。化合物12a可能是开发强效 HPSE1 抑制剂的新型先导化合物。

  DOI：

  10.1016/j.bmcl.2022.129050
• 作为产物：
  描述：

  2,4-二甲氧基-6-甲基苯甲醛 在 palladium on activated charcoal 氢氧化钾 、 sodium chlorite 、 sodium dihydrogenphosphate 、 氢气 、 三溴化硼 、 potassium carbonate 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 lithium diisopropyl amide 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 、 水 、 二甲基亚砜 、 乙酸乙酯 、 丙酮 、 乙腈 为溶剂， -78.0~90.0 ℃ 、101.33 kPa 条件下， 反应 89.33h， 生成 2,4-二羟基-6-十五烷基苯甲酸
  参考文献：
  名称：

  Total Synthesis of CRM646-A and -B, Two Fungal Glucuronides with Potent Heparinase Inhibition Activities

  摘要：

  CRM646-A (1) and -B (2), two fungal glucuronides with a dimeric 2,4-dihydroxy-6-alkylbenzoic acid (orcinolp-depside) aglycone showing significant heparinase and telomerase inhibition activities, were synthesized for the first time. The successful approach involved construction of the phenol glucuronidic linkage, via coupling of the orsellinate derivative 27 with glucuronate bromide 7, before assembly of the phenolic ester linkage in the depside aglycone. Attempts via direct glycosylation of the depside aglycone derivatives were not successful.

  DOI：

  10.1021/jo051384k

文献信息

• Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative
  作者：Massimo Ghizzoni、André Boltjes、Chris de Graaf、Hidde J. Haisma、Frank J. Dekker

  DOI：10.1016/j.bmc.2010.06.089

  日期：2010.8

  Several lines of evidence indicate that histone acetyltransferases (HATs) are novel drug targets for treatment of diseases like, for example, cancer and inflammation. The natural product anacardic acid is a starting point for development of small molecule inhibitors of the histone acetyltransferase (HAT) p300/CBP associated factor (PCAF). In order to optimize the inhibitory potency, a binding model for PCAF inhibition by anacardic acid was proposed and new anacardic acid derivatives were designed. Ten new derivatives were synthesized using a novel synthetic route. One compound showed a twofold improved inhibitory potency for the PCAF HAT activity and a twofold improved inhibition of histone acetylation in HEP G2 cells. (C) 2010 Elsevier Ltd. All rights reserved.
• Alkylresorcylic acid synthesis by type III polyketide synthases from rice Oryza sativa
  作者：Miku Matsuzawa、Yohei Katsuyama、Nobutaka Funa、Sueharu Horinouchi

  DOI：10.1016/j.phytochem.2010.02.012

  日期：2010.7

  Alkylresorcinols, produced by various plants, bacteria, and fungi, are bioactive compounds possessing beneficial activities for human health, such as anti-cancer activity. In rice, they accumulate in seedlings, contributing to protection against fungi. Alkylresorcylic acids, which are carboxylated forms of alkylresorcinols, are unstable compounds and decarboxylate readily to yield alkylresorcinols. Genome mining of the rice Oryza sativa identified two type III polyketide synthases, named ARAS1 (alkylresorcylic acid synthase) and ARAS2, that catalyze the formation of alkylresorcylic acids. Both enzymes condensed fatty acyl-CoAs with three C-2 units from malonyl-CoA and cyclized the resulting tetraketide intermediates via intramolecular C-2 to C-7 aldol condensation. The alkylresorcylic acids thus produced were released from the enzyme and decarboxylated non-enzymatically to yield alkylresorcinols. This is the first report on a plant type III polyketide synthase that produces tetraketide alkylresorcylic acids as major products. (C)2010 Published by Elsevier Ltd.
• Bruce, Ian; Spencer, Robert; Tyman, John, Journal of Chemical Research, Miniprint, 1992, # 7, p. 1773 - 1795
  作者：Bruce, Ian、Spencer, Robert、Tyman, John

  DOI：——

  日期：——
• Total Synthesis of CRM646-A and -B, Two Fungal Glucuronides with Potent Heparinase Inhibition Activities
  作者：Ping Wang、Zhaojun Zhang、Biao Yu

  DOI：10.1021/jo051384k

  日期：2005.10.1

  CRM646-A (1) and -B (2), two fungal glucuronides with a dimeric 2,4-dihydroxy-6-alkylbenzoic acid (orcinolp-depside) aglycone showing significant heparinase and telomerase inhibition activities, were synthesized for the first time. The successful approach involved construction of the phenol glucuronidic linkage, via coupling of the orsellinate derivative 27 with glucuronate bromide 7, before assembly of the phenolic ester linkage in the depside aglycone. Attempts via direct glycosylation of the depside aglycone derivatives were not successful.
• Lead identification of novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent heparanase-1 inhibitor
  作者：Yudai Imai、Daisuke Wakasugi、Ryo Suzuki、Sota Kato、Mami Sugisaki、Masashi Mima、Hiroh Miyagawa、Mayumi Endo、Natsuko Fujimoto、Takuya Fukunaga、Sayaka Kato、Shoichi Kuroda、Teisuke Takahashi、Hiroyuki Kakinuma

  DOI：10.1016/j.bmcl.2022.129050

  日期：2023.1

  (GUSβ) inhibitor, was found to have a weak inhibitory activity against endo-β-d-glucuronidase HPSE1. A structure–activity relationship study using the X-ray co-crystal structure of 10 and HPSE1 resulted in 12a, which showed a more than 14-fold increase in HPSE1 inhibitory activity compared with that of 10. Compound 12a could be a novel lead compound for the development of a potent HPSE1 inhibitor.

  乙酰肝素酶 1 (HPSE1) 是一种内切-β- d - 葡萄糖醛酸酶，可将硫酸乙酰肝素蛋白多糖切割成短链硫酸乙酰肝素 (HS)。HPSE1 的抑制对肾病综合征等蛋白尿疾病具有治疗潜力，因为 HPSE1 表达增加与肾小球基底膜中 HS 的丢失有关，从而导致蛋白尿的发展。本研究检查了先导化合物的生成，重点关注具有糖基的化学结构，例如糖苷和糖类似物，同时考虑了它们的物理特性。化合物10是一种外切-β- d -葡萄糖醛酸酶 (GUSβ) 抑制剂，被发现对内切具有微弱的抑制活性-β- d -葡萄糖醛酸酶 HPSE1。使用10和 HPSE1的 X 射线共晶结构进行的构效关系研究产生了12a ，与10相比，其 HPSE1 抑制活性增加了 14 倍以上。化合物12a可能是开发强效 HPSE1 抑制剂的新型先导化合物。